Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance

Finance
2



[
Xeris Biopharma stock up nearly 3% after Q4 EPS beat, above estimate guidance
[og_img]
https://www.investing.com/news/earnings/xeris-biopharma-stock-up-nearly-3-after-q4-eps-beat-above-estimate-guidance-93CH-4534406


Investing.com

Montather Rassoul
Montather Rassoulhttps://thefifthskill.com/

Latest articles

spot_imgspot_img
Previous article
European markets slide as Iran ‘war trade’ joins the global AI ‘scare trade’ 
Next article
U.S. war with Iran forces CEOs to prepare for the worst

Related articles

spot_imgspot_img